Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines

被引:80
作者
Angelucci, A [1 ]
D'Ascenzo, S [1 ]
Festuccia, C [1 ]
Gravina, GL [1 ]
Bologna, M [1 ]
Dolo, V [1 ]
Pavan, A [1 ]
机构
[1] Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy
关键词
membrane vesicles; prostate cancer; tumor invasion; urokinase plasminogen activator;
D O I
10.1023/A:1006778000173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ability of a cell to modify the extracellular matrix is important in several pathophysiological alterations including tumorigenesis. Cell transformation is accompanied by changes in the surrounding stroma as a result of the action of specific proteases such as the urokinase plasminogen activator (uPA), which has been associated with invasive potential in many tumor types. In this study, we analyzed the release of vesicle-associated uPA by the aggressive prostatic carcinoma cell line PC3 and the implications of this release for the invasive behaviour of prostatic tumor cells. Zymography and Western blot analysis revealed the presence of vesicle-associated uPA in the high-molecular weight form. Vesicles adhered to and degraded both collagen IV and reconstituted basal membrane (Matrigel), and plasminogen enhanced the degradation in a dose-dependent manner. Addition of membrane vesicles shed by PC3 cells to cultures of the poorly invasive prostate cancer cell line LnCaP enhanced the adhesive and invasive capabilities of the latter, suggesting a mechanism involving substrate recognition and degradation. Together, these findings indicate that membrane vesicles can promote tumor invasion and point to the important role of vesicle-associated uPA in the extracellular compartment.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 30 条
  • [1] ALBINI A, 1987, CANCER RES, V47, P3239
  • [2] Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
    Basbaum, CB
    Werb, Z
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (05) : 731 - 738
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I STABILIZES VITRONECTIN-DEPENDENT ADHESIONS IN HT-1080 CELLS
    CIAMBRONE, GJ
    MCKEOWNLONGO, PJ
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 111 (05) : 2183 - 2195
  • [5] ACCESSIBILITY OF RECEPTOR-BOUND UROKINASE TO TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    CUBELLIS, MV
    ANDREASEN, P
    RAGNO, P
    MAYER, M
    DANO, K
    BLASI, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 4828 - 4832
  • [6] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [7] Dolo V, 1998, CANCER RES, V58, P4468
  • [8] DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173
  • [9] Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
    Dolo, V
    D'Ascenzo, S
    Violini, S
    Pompucci, L
    Festuccia, C
    Ginestra, A
    Vittorelli, ML
    Canevari, S
    Pavan, A
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (02) : 131 - 140
  • [10] MEMBRANE-VESICLES SHED INTO THE EXTRACELLULAR MEDIUM BY HUMAN BREAST-CARCINOMA CELLS CARRY TUMOR-ASSOCIATED SURFACE-ANTIGENS
    DOLO, V
    ADOBATI, E
    CANEVARI, S
    PICONE, MA
    VITTORELLI, ML
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1995, 13 (04) : 277 - 286